Movatterモバイル変換

Teneligliptin

From Wikipedia, the free encyclopedia

Chemical compound

Pharmaceutical compound

Teneligliptin
Clinical data

Trade names	Tenelia
ATC code	A10BH08 (WHO)
Legal status
Legal status	Approved in Japan
Identifiers
IUPAC name {(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl}(1,3-thiazolidin-3-yl)methanone
CAS Number	760937-92-6
PubChemCID	11949652
ChemSpider	10123963
UNII	28ZHI4CF9C
CompTox Dashboard(EPA)	DTXSID30997419
Chemical and physical data
Formula	C₂₂H₃₀N₆OS
Molar mass	426.58 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CC1=NN(C(=C1)N2CCN(CC2)[C@H]3C[C@H](NC3)C(=O)N4CCSC4)C5=CC=CC=C5
InChI InChI=1S/C22H30N6OS/c1-17-13-21(28(24-17)18-5-3-2-4-6-18)26-9-7-25(8-10-26)19-14-20(23-15-19)22(29)27-11-12-30-16-27/h2-6,13,19-20,23H,7-12,14-16H2,1H3/t19-,20-/m0/s1 Key:WGRQANOPCQRCME-PMACEKPBSA-N

Teneligliptin (INN; trade nameTenelia) is a pharmaceutical drug for the treatment oftype 2 diabetes mellitus. It belongs to the class of anti-diabetic drugs known asdipeptidyl peptidase-4 inhibitors or "gliptins".^[1]

It was created byMitsubishi Tanabe Pharma and launched in September 2012 by both Mitsubishi Tanabe Pharma andDaiichi Sankyo inJapan.^[2]

It is approved for use in Japan, Argentina, Korea and India.^[3]

Teneligliptin has unique J-shaped or anchor locked domain structure because of which it has a potent inhibition of DPP 4 enzyme.

Teneligliptin significantly controls glycemic parameters with safety. No dose adjustment is required in renally impaired patients.^[4]

^Kishimoto M (2013)."Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes".Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.6:187–195.doi:10.2147/DMSO.S35682.PMC 3650886.PMID 23671395.
^"TENELIA® 20mg tablets, a Treatment for Type 2 Diabetes Mellitus Approval of Partial Change in Indication to Lift Restrictions in Combination Therapy".Media & Investors. Daiichi Sankyo. 20 December 2013. Archived fromthe original on 24 November 2015.
^Bronson J, Black A, Dhar TG, Ellsworth BA, Merritt JR (2013). "Teneligliptin (Antidiabetic), Chapter: To Market, To Market - 2012".Annual Reports in Medicinal Chemistry. Vol. 48. pp. 523–524.doi:10.1016/b978-0-12-417150-3.00028-4.ISBN 978-0-12-417150-3.
^Nabeno M, Akahoshi F, Kishida H, Miyaguchi I, Tanaka Y, Ishii S, Kadowaki T (May 2013). "A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site".Biochemical and Biophysical Research Communications.434 (2):191–196.doi:10.1016/j.bbrc.2013.03.010.PMID 23501107.

fast-acting	Insulin aspart Insulin glulisine Insulin lispro
short-acting	Regular insulin^#
long-acting	Insulin detemir^# Insulin glargine^# (+lixisenatide) NPH insulin Lente insulin^‡ Ultralente insulin^‡
ultra-long-acting	Insulin degludec^# (+insulin aspart,+liraglutide) Insulin icodec^† (+semaglutide)
inhalable	Exubera^‡ Afrezza
Oral	Insulin tregopil^†

Non-insulins

Biguanides	Buformin^‡ Metformin^# Phenformin^‡
TZDs/"glitazones" (PPAR)	Ciglitazone^§ Darglitazone^§ Englitazone^§ Lobeglitazone Netoglitazone^§ Pioglitazone Rivoglitazone^† Rosiglitazone Troglitazone^‡
Dual PPAR agonists	Aleglitazar^† Muraglitazar^§ Saroglitazar Tesaglitazar^§
Amylin analogues andDACRAs	Cagrilintide^§ Pramlintide

Sulfonylureas	1st generation:Acetohexamide Carbutamide Chlorpropamide Glycyclamide Metahexamide Tolazamide Tolbutamide 2nd generation:Glibenclamide (glyburide) Glibornuride Glicaramide Gliclazide^# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide
Meglitinides/"glinides"	Mitiglinide Nateglinide Repaglinide

GLP1 poly-agonist peptides	Mazdutide (GLP-1/GCGR) Retatrutide^§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP)

Other

Aldose reductase inhibitors	Epalrestat Fidarestat^§ Ranirestat^† Tolrestat^‡ Zenarestat^§
Alpha-glucosidase inhibitors	Acarbose Miglitol Voglibose
SGLT2 inhibitors/"gliflozins"	Canagliflozin Dapagliflozin Empagliflozin^# Ertugliflozin Ipragliflozin Luseogliflozin Remogliflozin^§ Sergliflozin^§ Sotagliflozin Tofogliflozin^† Velagliflozin
Other	Benfluorex^‡ Bromocriptine Imeglimin

Hidden categories: